HIV treatment and prevention on every 2026 Michigan Part D plan
Pick a drug class, or type the drugs you want to check, and see which of the 12 stand-alone Part D plans in Michigan cover each one, on what tier, and with what restrictions.
- Covered
- Covered, needs prior authorization (PA) or step therapy (ST)
- Not on the formulary
- QL 60/30d = quantity limit, 60 units per 30 days
12 plans, cheapest premium first. Scroll sideways for all of them →
| Drug | Wellcare Classic$0.00/moS4802-084 | Wellcare Value Script$0.00/moS4802-148 | HealthSpring Assurance Rx$0.00/moS5617-221 | Humana Basic Rx Plan$0.00/moS5884-136 | Humana Value Rx Plan$0.00/moS5884-192 | AARP Medicare Rx Saver from UHC$14.10/moS5921-358 | HealthSpring Extra Rx$50.40/moS5617-363 | SilverScript Choice$78.30/moS5601-026 | AARP Medicare Rx Preferred from UHC$78.30/moS5921-394 | Prescription Blue Select$78.40/moS5584-001 | Humana Premier Rx Plan$98.10/moS5884-159 | Prescription Blue Premium$106.70/moS5584-002 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biktarvybictegravir/emtricitabine/tenofovir alafenamide | Tier 525% | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 531%QL 30/30d | Tier 525%QL 31/31d | Tier 533%QL 30/30d | Tier 533%QL 31/31d |
| Dovatodolutegravir and lamivudine | Tier 525% | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 531%QL 30/30d | Tier 525% | Tier 533%QL 30/30d | Tier 533% |
| Triumeqabacavir/dolutegravir/lamivudine | Tier 428% | Tier 440% | Tier 430%QL 300/30d | Tier 433%QL 180/30d | Tier 433%QL 180/30d | Tier 433%QL 180/30d | Tier 432%QL 300/30d | Tier 433% | Tier 432%QL 180/30d | Tier 425%QL 180/30d | Tier 450%QL 180/30d | Tier 427%QL 180/30d |
| Genvoyaelvitegravir/cobicistat/emtricitabine/tenofovir alafenamide | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 531%QL 30/30d | Tier 525%QL 31/31d | Tier 533%QL 30/30d | Tier 533%QL 31/31d |
| Odefseyemtricitabine/rilpivirine/tenofovir alafenamide | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 531%QL 30/30d | Tier 525% | Tier 533%QL 30/30d | Tier 533% |
| Symtuzadarunavir/cobicistat/emtricitabine/tenofovir alafenamide | Tier 525% | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 531%QL 30/30d | Tier 525% | Tier 533%QL 30/30d | Tier 533% |
| Julucadolutegravir and rilpivirine | Tier 525% | Tier 525% | Tier 525% | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 525% | Tier 531%QL 30/30d | Tier 525%QL 31/31d | Tier 533%QL 30/30d | Tier 533%QL 31/31d |
| Descovyemtricitabine and tenofovir alafenamide | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 526%QL 30/30d | Tier 525%QL 30/30d | Tier 525%QL 30/30d | Tier 525% | Tier 531%QL 30/30d | Tier 525%QL 31/31d | Tier 533%QL 30/30d | Tier 533%QL 31/31d |
| Truvadaemtricitabine and tenofovir disoproxil | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered | Not covered |
| emtricitabine-tenofovirgeneric Truvada | Tier 428%QL 30/30d | Tier 440%QL 30/30d | Tier 430%QL 30/30d | Tier 433%QL 30/30d | Tier 433%QL 30/30d | Tier 433%QL 30/30d | Tier 432%QL 30/30d | Tier 433%QL 30/30d | Tier 432%QL 30/30d | Tier 320%QL 31/31d | Tier 450%QL 30/30d | Tier 324%QL 31/31d |
| Tivicaydolutegravir | Tier 525% | Tier 525% | Tier 430%QL 180/30d | Tier 525%QL 60/30d | Tier 526%QL 60/30d | Tier 525%QL 60/30d | Tier 432%QL 180/30d | Tier 525% | Tier 531%QL 60/30d | Tier 525%QL 62/31d | Tier 533%QL 60/30d | Tier 533%QL 62/31d |
Where a plan covers several strengths or forms of a drug, the cell shows the least restricted one. Costs are the 30-day preferred-pharmacy cost-sharing in the initial coverage phase, from the CMS 2026 formulary files. Click a plan for its full drug list.